a a Trends & Opportunities
in Early Growth Markets
    MicroRNA Analysis
 
Life Science
Dashboard™
 
  2012 Dashboards:
    Protein Electrophoresis and Western Analysis
  2011 Dashboards:
    Nucleic Acid Purification
    Nucleic Acid Amplification
    Flow Cytometry
    Quantitative Immunoassays
  2010 Dashboards:
    Gene Silencing
    Cell Culture
    Gene Expression Profiling
  2009 Dashboards:
    Transfection
    Nucleic Acid Amplification
    Nucleic Acid Purification
  2008 Dashboards:
    Cell Culture
    Gene Expression Profiling
    Gene Silencing
    Nucleic Acid Separation
  2007 Dashboards
 
  Life Science Marketing
Series
  Subscribe
  Privacy Policy
Publications: 2008 MicroRNA Analysis in North America : Trends & Opportunities in Early Growth Markets
Catalog number: 0810MIRNA
Publication date: October 2008
Company-wide electronic copy: $2,995

Please enquire about single-user* electronic
copy pricing
*single-user pricing is intended for small companies of 40 or
less employees. Please order these copies directly with Percepta Associates.
 
Overview
Interest in non-coding RNA has exploded in recent years. The diverse function and roles of microRNA (miRNA) in disease and development has captured the interest of the research community. The promise of miRNAs serving as useful biomarkers in clinical diagnostics and therapeutic targets has already led to several clinical trials, acquisitions, startups and spinouts as companies and investors look to capitalize on the potential.

Percepta’s MicroRNA Analysis In North America: A Market Research Report For Life Science Tool Providers takes a close look at the endogenous miRNA research market in the United States and Canada. This report was developed through a combination of primary market research of active miRNA researchers collected in interviews and online questionnaires as well as secondary market research on the suppliers, technologies, and commercial products. This Trends & Opportunities in Early Growth Markets report is designed to provide research tool providers valuable insights into the current miRNA research market and the technologies driving it.

Highlights of this report include:
• Comprehensive Technology Review
• miRNA Market Insights
• miRNA Researcher Profile
• Overall Market Size and Growth Estimates
• Supplier Opportunities Analysis

The Trends & Opportunities in Early Growth Markets report focuses on the following market sub-segments:
• miRNA Purification
• miRNA Cloning
• miRNA Microarray Labeling
• miRNA Microarrays
• miRNA Sequencing
• miRNA qRT-PCR
• miRNA Functional Analysis: Inhibitors and Over-expression
• miRNA Localization
• miRNA Target Analysis Participant Demographics for the Online Survey and Telephone Interviews

Participants from the academic, government and commercial market segments are well represented, with nearly 15% of respondents employed in an industry setting. The majority (63%) of respondents are currently working at a University, College, or Medical School. All participants are located in the United States or Canada.

Participants hold diverse roles at their institutions. Junior (Lab Tech, Grad Students), mid level (Post-Doc, Lab Manager) and senior (Professor/PI, Group Leader) scientists are well represented in the data set, with the most cited job titles being Post-Doctoral Fellow (23%), Senior Scientist (18%) and Graduate Student (15%).

A wide variety of scientific areas of specialization is also evident, led by Molecular Biology (25%), Cell Biology (12%), Biochemistry (9%) and Genomics (7%). Participants indicating eighteen additional scientific areas of specialization comprise the remainder.

Small (1 to 5 scientists), mid-size ( 6 to 10 scientists) and large laboratories (>10 scientists) are well represented in the respondent data set: 38% of respondents work in labs where 1-5 people regularly perform experiments, followed by 35% of respondents working in labs where 6-10 people perform experiments. Larger labs (>10 researchers) account for 27% of participants.
Site Map | Privacy Policy | © 2005-2012 Percepta Associates Inc.